Form D · Other Technology
Diligent Pharma, Inc.
Princeton, NJ · CIK 0001965661
Offering snapshot reported Feb 16, 2023 · SEC filing
- Reported sold
- $3.5M Offering amount: $9.25M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Feb 2, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 16, 2023 | Initial | $3,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-473674
Source: Form D, filed Feb 16, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patricia Leuchten | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
179 Nassau Street Suite 3 A
Princeton, NJ, 08542
Princeton, NJ, 08542